Home

RECOMBINANT PROTEINS
PREVIOUSLY OUT OF REACH

SCALABLE VIRAL VECTOR PRODUCTION

C1-INHIBITOR AND ALKALINE
PHOSPHATASE: GLYCO-OPTIMIZED
FOR THERAPEUTIC NEEDS

STABLE AAV PRODUCER CELL LINES

Meet us at

26th Annual Congress of the ESGCT

10/16/2018 – 10/19/2018
LAUSANNE, SWITZERLAND

 

Career

Open positions

Technischer Assistent Zelllinienentwickelung / Virale Vektoren (m/w)

NEWSLETTER

Subscribe for the CEVEC Newsletter according to our Privacy Policy to receive the latest CEVEC News, including Press Releases, Conference Information and Webinar Invitations.

© Copyright – CEVEC 2018